Today's Breaking News
- Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease
- OncoSec Medical Announces Completion of Enrollment of Phase II Metastatic Melanoma Trial
- Merus Presents Preclinical Data on its Novel Bispecific Antibody MCLA-117 at EHA 2013
Latest R&D and Business News
- Karolinska Development AB (publ): Athera and Boehringer Ingelheim enter into an option agreement on a novel therapy for Atherosclerosis
- Kitasato Daiichi Sankyo Vaccine Submits a New Drug Application in Japan for the Cell Culture-Based Pandemic Influenza Vaccine
- AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza (saxagliptin)
- Curie-Cancer and Sanofi cooperate in research on ovarian cancer
- Mei Pharma Initiates Phase II Clinical Trial Of Pracinostat And Vidaza® In Frontline Myelodysplastic Syndrome
- PhaseBio Expands Clinical Development of Vasomera, an Investigational Treatment for Cardiopulmonary Diseases
- iCo Therapeutics Announces Completion of Trial Enrollment and Clinical Update for iDEAL Phase 2 Study for the Treatment of Diabetic Macular Edema
- TWi Biotechnology Announces Completion of Patient Enrollment in Gout Flare Prophylaxis Phase II Trial for AC-201
- Moffitt Cancer Center Announces Strategic Partnership with Advinus Therapeutics
- "PRIMARYS" Study Investigators Observed Clinically Relevant Results in an Investigational Phase III Study with Somatuline® Autogel 120 mg in Patients with Acromegaly
- Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
- New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia